Ríos-Prego Mónica, Anibarro Luis, Sánchez-Sobrino Paula
Department of Internal Medicine, Pontevedra University Hospital Complex, Pontevedra, Spain.
Department of Endocrinology and Nutrition, Pontevedra University Hospital Complex, Pontevedra, Spain.
Int J Gen Med. 2019 Aug 23;12:299-304. doi: 10.2147/IJGM.S206983. eCollection 2019.
Hypothyroidism has traditionally been associated with obesity, whereas hyperthyroidism has been linked to being underweight. However, very few studies have assessed these associations. The aim of this work is to evaluate the association between thyroid dysfunction and body mass index (BMI) at baseline and after normalization of the hormone levels.
A retrospective, observational study of a cohort of otherwise healthy patients that were referred for evaluation of thyroid dysfunction to the Endocrine Department of Pontevedra University Complex Hospital, Spain was conducted. We collected data of BMI and thyroid hormone levels before treatment and after normalization of thyroid function within a follow-up period of 12 months.
A total of 330 patients were initially selected for the study. In order to exclude variables that for any reason could influence on BMI, 235 were excluded for further studies. Another 61 patients were also excluded because incomplete data on their medical records, failure to achieve euthyroidism, or lost to follow-up. Therefore, the eligible final study group consisted of 34 patients (17 with hypothyroidism and 17 with hyperthyroidism). No differences were observed in mean baseline BMI between hypo and hyperthyroid patients (27.07±3.22 vs 26.39±4.44, =0.609). Overweight or obesity was observed in 76.5% and 58.8% of hypothyroid and hyperthyroid patients, respectively (=0.23). After normalization of thyroid function, the weight of hypothyroid patients decreased from 70.93±10.06 kg to 68.68±10.14 (=0.000), while the weight of hyperthyroid patients increased from 65.45±11.64 kg to 68.37±12.80 (=0.000). Their mean BMI was 26.22±3.36 and 27.57±4.98 (=0.361) for hypo- and hyperthyroid patients, respectively. 58.8% and 64.7% patients remained in the overweight/obesity range in each group (=0.72).
Untreated thyroid dysfunction is not associated with BMI. Normalization of thyroid levels significantly changed the weight of patients, but remaining most patients within overweight ranges.
传统观点认为甲状腺功能减退与肥胖有关,而甲状腺功能亢进则与体重过轻有关。然而,很少有研究评估这些关联。本研究的目的是评估甲状腺功能障碍与基线时以及激素水平正常化后的体重指数(BMI)之间的关联。
对西班牙蓬特韦德拉大学综合医院内分泌科转诊来评估甲状腺功能障碍的一组其他方面健康的患者进行了一项回顾性观察研究。我们收集了治疗前以及在12个月的随访期内甲状腺功能正常化后的BMI和甲状腺激素水平数据。
最初共选择了330例患者进行研究。为了排除任何可能影响BMI的变量,另外235例被排除用于进一步研究。另有61例患者也被排除,原因是其病历数据不完整、未实现甲状腺功能正常或失访。因此,符合条件的最终研究组由34例患者组成(17例甲状腺功能减退患者和17例甲状腺功能亢进患者)。甲状腺功能减退和亢进患者的平均基线BMI无差异(27.07±3.22对26.39±4.44,P=0.609)。甲状腺功能减退和亢进患者中分别有76.5%和58.8%的患者超重或肥胖(P=0.23)。甲状腺功能正常化后,甲状腺功能减退患者的体重从70.93±10.06千克降至68.68±10.14千克(P=0.000),而甲状腺功能亢进患者的体重从65.45±11.64千克增至68.37±12.80千克(P=0.000)。甲状腺功能减退和亢进患者的平均BMI分别为26.22±3.36和27.57±4.98(P=0.361)。每组中分别有58.8%和64.7%的患者仍处于超重/肥胖范围内(P=0.72)。
未经治疗的甲状腺功能障碍与BMI无关。甲状腺水平正常化显著改变了患者的体重,但大多数患者仍处于超重范围内。